ImExHS And 2 Other Australian AI Healthcare Stocks To Watch

The US Federal Reserve just lifted interest rates for the first time in three years, reminding investors that easy money is not guaranteed. Higher borrowing costs tend to reward businesses that can cut waste and use data intelligently. Australian companies applying artificial intelligence to healthcare sit right in that sweet spot. This article walks through three AI driven healthcare stocks from our screener that may help you consider how to position for this shift.

The three stocks below are a useful sample, but the full screen surfaced 4 more AI driven healthcare companies with equally compelling stories that are not covered here. To see the complete picture, head straight to the Transformative Artificial intelligence (AI) Healthcare Stocks screener to identify, filter, and analyze the highest conviction ideas aligned with your own risk profile.

ImExHS (ASX:IME)

ImExHS plugs directly into the AI healthcare theme through its cloud-based imaging platforms and teleradiology services. These generate the annotated scan data that machine learning tools need to sharpen diagnostics and streamline hospital workflows.

ImExHS earns about A$10 million from software and A$21 million from radiology services, with all reported revenue coming from Latin America, and has a market value of roughly A$18 million.

"They also understand the challenge now is to drive the software sales and revenue much faster in 2026."

What happens to ImExHS’s appeal if a single unseen pressure quietly shifts how profitable each new scan and AI data contract becomes?

If that unseen pressure matters to you, read the full narrative for ImExHS to see how ImExHS’s data engine, capital needs, and contract mix could be decoupling.

Singular Health Group (ASX:SHG)

Singular Health Group builds 3DICOM software that converts CT, MRI and PET scans into 3D models and runs AI in the Cloud to apply AI models to those images. The company earns about A$1.9 million from this medical technology and has a market value near A$62 million.

Singular Health Group operates in AI driven imaging, using cloud tools to help clinicians interpret scans more accurately and share them efficiently. Revenue of A$1.43 million in 2026 and a reported loss of A$6.34 million show an early stage profile that could change significantly if adoption patterns for AI imaging shift, depending on how the market develops.

That kind of swing can flip quickly, so scan the analysis report for Singular Health Group to see what the current numbers might be masking for Singular Health Group.

Artrya (ASX:AYA)

Artrya pushes the screener theme into the cardiology ward by using cloud-based AI to read coronary CT angiography scans and flag heart attack risk in real time.

Artrya develops Salix, an AI-driven cardiac imaging platform that automates coronary artery disease assessment from coronary CT angiography scans. The business currently books about A$0.03 million from AI CCTA image analysis in Australia and carries a market value near A$535 million.

"Growing adoption of CCTA as a front-line tool for chest pain assessment, together with up to 400,000 scans a year across SAPPHIRE partners at a blended rate of about US$850 per scan across three modules, gives Artrya a clear volume pathway that directly targets future subscription and fee per scan revenue."

What happens to Artrya’s earnings power if a single assumption about how quickly those scans convert into paid software usage quietly shifts?

If that shift in conversion speed matters, read the full narrative for Artrya to see whether Artrya’s volume pathway is accelerating, stalled, or quietly being re-rated.

Seeking Alternatives Before Momentum Flies

Fresh ideas rarely stay quiet for long. Once momentum builds, entry points can vanish fast while the crowd chases late. Scan these under the radar for now and act based on your own research and judgment.

• Target dependable income streams by reviewing the 4 dividend fortresses that combine high yields with balance sheets built to handle pressure before everyone else chases them.
• Spot under followed future tech leaders by working through the 25 quantum computing stocks and get eyes on potential multiyear themes before attention floods in.
• Track the next infrastructure momentum wave by checking the 38 power grid technology and infrastructure stocks for businesses positioned around critical grid upgrades while interest is still building.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com